Atlas Trials

BOTOX Effects on Seizure Severity and Susceptibility

Clinical trial NCT05605756 · TERMINATED

Trial details

NCT number
NCT05605756
Sponsor
Beth Israel Deaconess Medical Center
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Drug-resistant Focal Seizure
Start date
2023-03-01
Primary completion
2024-12-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.